Anyone sees this as a unicorn, i.e. $1 billion company ?
Well, I can see and feel it just from the CannEpil......
100 patients to generate $1million
According to WHO, there are about 50 million people world wide with Epilesy. So, market size is about A$500 billion. If MXC can just take 0.1%....it will generate A$500 million per year. Assuming 20% net profit, it will be a A$100 million profit company. Unicorn is definitely possible yah since MXC is soon going to have a fully GMP certified production facility based in Europe.
Let's rock and roll....
Anyone sees this as a unicorn, i.e. $1 billion company ? Well, I...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.125(43.9%) |
Mkt cap ! $7.986M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 15.0¢ | $41.27K | 245.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20622 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 150 | 1 |
View Market Depth
| Last trade - 12.30pm 15/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |